Involvement of deoxycytidylate deaminase in the response to Sn1-type methylation DNA damage in budding yeast

Current Biology

Volumn 17, Issue 17, 2007, Pages

  Liskay, R Michael ^a   Wheeler, Linda J ^b   Mathews, Christopher K ^b   Erdeniz, Naz ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCYTIDINE PHOSPHATE DEAMINASE; METHYLNITRONITROSOGUANIDINE;

ANTIFUNGAL RESISTANCE; DNA DAMAGE; DNA METHYLATION; ENZYMOLOGY; GENETICS; LETTER; METABOLISM; MISMATCH REPAIR; SACCHAROMYCES;

DCMP DEAMINASE; DNA DAMAGE; DNA METHYLATION; DNA MISMATCH REPAIR; DRUG RESISTANCE, FUNGAL; METHYLNITRONITROSOGUANIDINE; SACCHAROMYCETALES;

MAMMALIA; SACCHAROMYCETALES;

EID: 34548283968     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2007.07.028     Document Type: Letter

References (15)

1. Iyer R.R., Pluciennik A., Burdett V., and Modrich P.L. DNA mismatch repair: functions and mechanisms. Chem. Rev. 106 (2006) 302-323
2. N)1-type methylating agents in S. cerevisiae. Curr. Biol. 15 (2005) 1395-1400
3. McIntosh E.M., and Haynes R.H. Isolation of a Saccharomyces cerevisiae mutant strain deficient in deoxycytidylate deaminase activity and partial characterization of the enzyme. J. Bacteriol. 158 (1984) 644-649
4. Kohalmi S.E., Glattke M., McIntosh E.M., and Kunz B.A. Mutational specificity of DNA precursor pool imbalances in yeast arising from deoxycytidylate deaminase deficiency or treatment with thymidylate. J. Mol. Biol. 220 (1991) 933-946
5. Kunz B.A., Henson E.S., Karthikeyan R., Kuschak T., McQueen S.A., Scott C.A., and Xiao W. Defects in base excision repair combined with elevated intracellular dCTP levels dramatically reduce mutation induction in yeast by ethyl methanesulfonate and N-methyl-N'-nitro-N-nitrosoguanidine. Environ. Mol. Mutagen. 32 (1998) 173-178
6. Muller E.G. Deoxyribonucleotides are maintained at normal levels in a yeast thioredoxin mutant defective in DNA synthesis. J. Biol. Chem. 269 (1994) 24466-24471
7. Meuth M. Role of deoxynucleoside triphosphate pools in the cytotoxic and mutagenic effects of DNA alkylating agents. Somatic Cell Genet. 7 (1981) 89-102
8. Weinberg G., Ullman B., and Martin Jr. D.W. Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc. Natl. Acad. Sci. USA 78 (1981) 2447-2451
9. Dare E., Zhang L.H., Jenssen D., and Bianchi V. Molecular analysis of mutations in the hprt gene of V79 hamster fibroblasts: effects of imbalances in the dCTP, dGTP and dTTP pools. J. Mol. Biol. 252 (1995) 514-521
10. Robins H.I., Chang S., Butowski N., and Mehta M. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr. Oncol. Rep. 9 (2007) 66-70
11. Karran P., Offman J., and Bignami M. Human mismatch repair, drug-induced DNA damage, and secondary cancer. Biochimie 85 (2003) 1149-1160
12. Wang J.Y., and Edelmann W. Mismatch repair proteins as sensors of alkylation DNA damage. Cancer Cell 9 (2006) 417-418
13. York S.J., and Modrich P. Mismatch repair-dependent iterative excision at irreparable O6-methylguanine lesions in human nuclear extracts. J. Biol. Chem. 281 (2006) 22674-22683
14. Yang G., Scherer S.J., Shell S.S., Yang K., Kim M., Lipkin M., et al. Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility. Cancer Cell 6 (2004) 139-150
15. Yoshioka K., Yoshioka Y., and Hsieh P. ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol. Cell 22 (2006) 501-510